Non-fatal overdose risk during and after opioid agonist treatment: A primary care cohort study with linked hospitalisation and mortality records

Non-fatal overdose risk during and after opioid agonist treatment: A primary care cohort study with linked hospitalisation and mortality records

Summary: Background: The initiation and cessation of opioid agonist treatment (OAT) have both been associated with elevated risk of fatal overdose. We examined risk of non-fatal overdose during OAT initiation and cessation and specifically between methadone versus buprenorphine recipients. Methods:...

Full description

Bibliographic Details
Main Authors: Eleni Domzaridou, Matthew J. Carr, Roger T. Webb, Tim Millar, Darren M. Ashcroft
Format: Article
Language:English
Published: Elsevier 2022-11-01
Series:The Lancet Regional Health. Europe
Subjects:
Opioid use disorder
Overdose
Methadone
Buprenorphine
Drug safety
CPRD
Online Access:http://www.sciencedirect.com/science/article/pii/S2666776222001855

Similar Items

Similar Items